{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T20:22:08Z","timestamp":1794255728900,"version":"4.9.0"},"reference-count":13,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ymgme.2026.110279","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T23:17:50Z","timestamp":1790291870000},"page":"110279","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Single-center real-world experience with givosiran for management of acute intermittent porphyria"],"prefix":"10.1016","volume":"149","author":[{"given":"Chanan","family":"Stauffer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Fierro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Evard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha","family":"Balwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ymgme.2026.110279_bb0005","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1002\/hep.29313","article-title":"Acute hepatic porphyrias: recommendations for evaluation and long-term management","volume":"66","author":"Balwani","year":"2017","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.ymgme.2026.110279_bb0010","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1093\/hmg\/ddy030","article-title":"From a dominant to an oligogenic model of inheritance with environmental modifiers in acute intermittent porphyria","volume":"27","author":"Lenglet","year":"2018","journal-title":"Hum. Mol. Genet."},{"issue":"12","key":"10.1016\/j.ymgme.2026.110279_bb0015","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.amjmed.2014.06.036","article-title":"Acute porphyrias in the USA: features of 108 subjects from porphyrias consortium","volume":"127","author":"Bonkovsky","year":"2014","journal-title":"Am. J. Med."},{"issue":"4","key":"10.1016\/j.ymgme.2026.110279_bb0020","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/bjh.14459","article-title":"Update review of the acute porphyrias","volume":"176","author":"Stein","year":"2017","journal-title":"Br. J. Haematol."},{"issue":"3","key":"10.1016\/j.ymgme.2026.110279_bb0025","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1053\/j.gastro.2022.11.034","article-title":"AGA clinical practice update on diagnosis and management of acute hepatic porphyrias: expert review","volume":"164","author":"Wang","year":"2023","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.ymgme.2026.110279_bb0030","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.amjmed.2014.10.026","article-title":"Role of delta-aminolevulinic acid in the symptoms of acute porphyria","volume":"128","author":"Bissell","year":"2015","journal-title":"Am. J. Med."},{"issue":"24","key":"10.1016\/j.ymgme.2026.110279_bb0035","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1056\/NEJMoa1913147","article-title":"Phase 3 trial of RNAi therapeutic givosiran for acute intermittent porphyria","volume":"382","author":"Balwani","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.ymgme.2026.110279_bb0040","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1016\/j.ekir.2021.04.004","article-title":"Renal function decline with small interfering RNA silencing Aminolevulinic acid synthase 1 (ALAS1)","volume":"6","author":"Lazareth","year":"2021","journal-title":"Kidney Int Rep."},{"issue":"4","key":"10.1016\/j.ymgme.2026.110279_bb0045","first-page":"262","article-title":"Elevated homocysteine is negatively correlated with plasma cystathionine \u03b2-synthase activity in givosiran-treated patients","volume":"65","author":"Keibler","year":"2024","journal-title":"JIMD Rep."},{"issue":"19","key":"10.1016\/j.ymgme.2026.110279_bb0050","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1182\/blood.2022018662","article-title":"RNA interference therapy in acute hepatic porphyrias","volume":"142","author":"Yasuda","year":"2023","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.ymgme.2026.110279_bb0055","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/liv.15090","article-title":"Efficacy and safety of givosiran for acute hepatic porphyria: 24-month interim analysis of the randomized phase 3 ENVISION study","volume":"42","author":"Ventura","year":"2022","journal-title":"Liver Int."},{"issue":"3","key":"10.1016\/j.ymgme.2026.110279_bb0060","article-title":"Real-world experience with Givosiran in acute porphyrias: a narrative review and a novel hypothesis","volume":"18","author":"Petrides","year":"2026","journal-title":"Cureus"},{"issue":"9","key":"10.1016\/j.ymgme.2026.110279_bb0065","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1080\/17474124.2022.2110469","article-title":"Hyperhomocysteinemia in acute hepatic porphyria (AHP) and implications for treatment with givosiran","volume":"16","author":"Ventura","year":"2022","journal-title":"Expert Rev. Gastroenterol. Hepatol."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719226005627?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719226005627?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T19:31:55Z","timestamp":1794252715000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719226005627"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S1096719226005627"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2026.110279","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Single-center real-world experience with givosiran for management of acute intermittent porphyria","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2026.110279","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110279"}}